NUCLEOME

Abstract

Analysis of data for medical and health purposes, namely, medical analysis for the diagnosis and treatment of persons; providing medical and health information and advice relating to genetics and pharmaceuticals; providing data being medical and health information relating to genetics and pharmaceuticals; pharmaceutical services, namely, pharmaceutical consultation, pharmaceutical compounding services; medical and healthcare services relating to DNA, genetics and genetic testing; providing an online computer database featuring information regarding health; consultancy, advisory and information services relating to the aforementioned services; Reagents for research use, other than for medical and veterinary purposes; chemical diagnostic reagents for industrial purposes, other than for medical and veterinary purposes; diagnostic reagents, other than for medical and veterinary purposes; kits for research, industry and diagnostic purposes, comprised of industrial chemicals, reagents for research use and diagnostic preparations for scientific use other than for medical and veterinary purposes; reagents for medical research; kits for medical research comprised of reagents for research use, diagnostic preparations for scientific use; biological preparations for use in industry and science; diagnostic biological preparations for research laboratory use; human cells and isogenic cell lines for research and scientific purposes, not for medical and veterinary use; Research and development services in the field of immunology; scientific research and development services; biotechnology research and development services; pharmaceutical research and development services; drug discovery; pharmaceutical drug development; research and development services in the field of genomics; structural and functional analysis of genomes; research and development services in the field of bioinformatics; research and development of personalised medicine; research and development of precision medicine; research and development of stratified medicine; research and development in the field of drug discovery; research and development in the field of drug target discovery; scientific research and development services in the field of clinical trial design for others; research and development services in the field of medical diagnostics preparations; research and development of pharmaceuticals and pharmaceutical compounds; research and development of pharmaceutical preparations and medicines; research and development of medicines; medical preparation research and development services; research related to genomics, bioinformatics, personalised medicine, precision medicine, drug discovery; design and development of databases; design and development of computer software; design and development of computer databases; database design and development services; computer database design and development services; design and development of computer software used for services in the field of pharmaceuticals, clinical trials, personalised medicine and genetics; design and development of computer database used for services in the field of pharmaceuticals, clinical trials, personalised medicine and genetics; genome interpretation services being structural and functional analysis of genomes; software as a service (SAAS) services featuring software for genome sequencing, annotation, interpretation and reporting; providing an online searchable database in the field of genome sequencing, annotation, interpretation, and reporting for scientific research purposes; software as a service (SAAS) services featuring software for drug discovery and research; providing an online searchable database in the field of drug discovery and research for scientific research purposes; software as a service (SAAS) services featuring software for potential patient identification and potential patient stratification; providing software as a service (SAAS) services featuring software for medical diagn...